MSK House, London Road, Silk Willoughby, Sleaford NG34 8NY
Blogs
Browse every article from Lincolnshire Knee.
ChondroFiller and Arthrosamid work on different anatomical targets within the knee—one repairing focal cartilage loss, the other managing diffuse osteoarthritis through a permanent hydrogel—and therefore rarely compete directly.
Knee pain divides into three tiers: emergencies requiring A&E (five specific red flags), urgent presentations needing same-day GP contact, and elective pain—most cases—safely managed through six weeks of conservative self-care.
For knee cartilage defects of three square centimetres or larger, MACI is the standard two-stage cell-based treatment in UK practice, having displaced first-generation ACI and demonstrating superiority over microfracture in the SUMMIT Phase 3 trial.
With each additional degree of posterior tibial slope, graft load rises and cumulative fatigue — not acute injury — becomes the dominant failure mechanism; at slopes of 12° or above, published data show graft rupture risk rises up to eighteen times higher than normal.
ChondroFiller injections provide meaningful relief from focal knee cartilage defects for 2–5 years in 70–85% of patients — markedly longer than steroid or viscosupplement alternatives.
Approximately 80% of patients with degenerative meniscus tears become asymptomatic with exercise therapy, even though the tear remains visible on MRI; major trials show surgery offers only marginal short-term benefit.
World-class orthopaedic surgeon
Consultant Cartilage Surgeon • Visiting Professor, University of Lincoln
Biology-led, faster return to activity.
Advanced OA injection for relief.
Keyhole cartilage regeneration.
“Regenerative science plus precise surgery and rehab can shorten recovery and protect long-term joint health.”
Ready to move again?
Self-referrals welcome. Insured and self-pay accepted.
